How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control

Verver, S; Walker, M; Kim, Y E; Fobi, G; Tekle, A H; Zouré, H G M; Wanji, S; Boakye, D A; Kuesel, A C; De Vlas, S J; Boussinesq, M; Basáñez, M-G; Stolk, W A

doi:10.1093/cid/cix1137

How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control

Verver, S; Walker, M; Kim, Y E; Fobi, G; Tekle, A H; Zouré, H G M; Wanji, S; Boakye, D A; Kuesel, A C; De Vlas, S J; Boussinesq, M; Basáñez, M-G; Stolk, W A

Authors

S Verver

M Walker

Y E Kim

G Fobi

A H Tekle

H G M Zouré

S Wanji

D A Boakye

A C Kuesel

S J De Vlas

M Boussinesq

M-G Basáñez

W A Stolk

Citation

Verver, S., Walker, M., Kim, Y. E., Fobi, G., Tekle, A. H., Zouré, H. G. M., …Stolk, W. A. (2018). How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control. Clinical Infectious Diseases, 66(4), S267-S274. https://doi.org/10.1093/cid/cix1137

Journal Article Type	Article
Acceptance Date	May 30, 2018
Publication Date	Jun 1, 2018
Deposit Date	Mar 8, 2018
Publicly Available Date	Jul 9, 2018
Journal	CLINICAL INFECTIOUS DISEASES
Print ISSN	1058-4838
Publisher	Oxford University Press
Peer Reviewed	Peer Reviewed
Volume	66
Issue	4
Pages	S267-S274
DOI	https://doi.org/10.1093/cid/cix1137
Public URL	https://rvc-repository.worktribe.com/output/1387022